Sulfamethizole

From WikiMD's WELLNESSPEDIA

(Redirected from Lucosil)

Chemical structure of sulfamethizole

Sulfamethizole is a sulfonamide antibiotic used in the treatment of bacterial infections. It is part of the sulfonamide class of drugs, which are synthetic antimicrobial agents that contain the sulfonamide group. Sulfamethizole is primarily used to treat urinary tract infections and other infections caused by susceptible strains of bacteria.

Mechanism of Action[edit]

Sulfamethizole works by inhibiting the bacterial enzyme dihydropteroate synthase, which is involved in the synthesis of folic acid. Bacteria require folic acid for the synthesis of nucleic acids and ultimately for DNA replication. By blocking this enzyme, sulfamethizole prevents bacteria from growing and multiplying.

Pharmacokinetics[edit]

Sulfamethizole is absorbed from the gastrointestinal tract and is distributed throughout the body. It is metabolized in the liver and excreted primarily in the urine. The drug's half-life allows for multiple daily dosing to maintain effective concentrations in the body.

Clinical Uses[edit]

Sulfamethizole is used to treat a variety of infections, including:

It is important to note that sulfamethizole should only be used for infections caused by bacteria that are susceptible to this antibiotic.

Side Effects[edit]

Common side effects of sulfamethizole include:

Serious side effects can occur, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, although these are rare.

Contraindications[edit]

Sulfamethizole is contraindicated in patients with:

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.